Eco Animal Health Group Plc(LSE) EAH

ECO Animal Health Group plc is a UK-based company specializing in the research, regulatory approval, and distribution of veterinary pharmaceutical solutions. Established in 1972, the company offers a range of products aimed at improving animal health, particularly in livestock and pets.

Products and Services

• Aivlosin, a macrolide antibiotic for pigs and poultry
• Generic drugs like Ecomectin and Ecoheart for parasitic infestations
• Chlortetracycline and Oxytetracycline for bacterial infections in livestock

Growth Outlook

• Recent quarterly revenue reached £48.1 million, indicating strong demand
• Gross profit margin improved to 47.7% in the latest quarter
• Positive cash flow from operations of £8.75 million supports future growth

Financial Highlights

• Trailing twelve-month revenue of £181.5 million reflects consistent performance
• Net income of £2.55 million reported in the latest quarter
• Current ratio of 3.42 indicates strong liquidity position

ECO Animal Health Group plc operates in the healthcare sector, focusing on veterinary pharmaceuticals. The company has established a solid reputation for its innovative products, particularly Aivlosin, which addresses critical health issues in livestock. The recent financial performance showcases a robust revenue stream and a healthy gross profit margin, suggesting effective cost management and operational efficiency. The growth outlook appears promising, with significant quarterly revenue and a strong cash flow position. This financial stability allows for potential reinvestment into research and development, further enhancing product offerings. The company's liquidity, as indicated by a current ratio of 3.42, provides a buffer against market fluctuations and supports ongoing operational needs. Overall, ECO Animal Health Group plc presents a compelling opportunity for investors interested in the veterinary pharmaceutical sector, backed by a history of innovation and a strong financial foundation.